Encompass Health Corporation $EHC Shares Purchased by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP boosted its stake in Encompass Health Corporation (NYSE:EHC) by 3.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,674,784 shares of the company’s stock after buying an additional 50,647 shares during the period. Dimensional Fund Advisors LP’s holdings in Encompass Health were worth $162,013,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the stock. WPG Advisers LLC increased its position in shares of Encompass Health by 73.3% during the fourth quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after acquiring an additional 137 shares during the last quarter. Flagship Harbor Advisors LLC acquired a new position in shares of Encompass Health in the 4th quarter worth approximately $37,000. Assetmark Inc. lifted its holdings in shares of Encompass Health by 89.6% in the 1st quarter. Assetmark Inc. now owns 455 shares of the company’s stock worth $44,000 after acquiring an additional 215 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its position in shares of Encompass Health by 36,200.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after purchasing an additional 362 shares during the period. Finally, Aster Capital Management DIFC Ltd acquired a new stake in Encompass Health in the 4th quarter valued at approximately $55,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Transactions at Encompass Health

In related news, EVP Patrick William Tuer sold 682 shares of Encompass Health stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president owned 24,755 shares in the company, valued at $2,588,382.80. The trade was a 2.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.80% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

EHC has been the topic of a number of research analyst reports. Barclays cut their target price on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Weiss Ratings downgraded Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, June 26th. Leerink Partners set a $152.00 target price on Encompass Health in a research note on Friday, May 22nd. Finally, TD Cowen initiated coverage on Encompass Health in a report on Thursday, May 28th. They set a “buy” rating and a $125.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $143.86.

Encompass Health Trading Up 1.4%

NYSE:EHC opened at $112.66 on Friday. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The firm has a market cap of $11.18 billion, a PE ratio of 18.81, a price-to-earnings-growth ratio of 2.46 and a beta of 0.74. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. The stock has a fifty day moving average price of $104.97 and a 200 day moving average price of $103.80.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.51 by $0.09. The company had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.Encompass Health’s revenue was up 9.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Sell-side analysts anticipate that Encompass Health Corporation will post 5.96 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 0.7%. This is a positive change from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Thursday, October 1st. Encompass Health’s dividend payout ratio is 12.69%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.